Cargando…
Circulating levels and prognostic cut‐offs of sST2, hs‐cTnT, and NT‐proBNP in women vs. men with chronic heart failure
AIMS: To define plasma concentrations, determinants, and optimal prognostic cut‐offs of soluble suppression of tumorigenesis‐2 (sST2), high‐sensitivity cardiac troponin T (hs‐cTnT), and N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) in women and men with chronic heart failure (HF). METHODS AN...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288762/ https://www.ncbi.nlm.nih.gov/pubmed/35510529 http://dx.doi.org/10.1002/ehf2.13883 |
_version_ | 1784748519606714368 |
---|---|
author | Vergaro, Giuseppe Gentile, Francesco Aimo, Alberto Januzzi, James L. Richards, A. Mark Lam, Carolyn S.P. de Boer, Rudolf A. Meems, Laura M.G. Latini, Roberto Staszewsky, Lidia Anand, Inder S. Cohn, Jay N. Ueland, Thor Gullestad, Lars Aukrust, Pål Brunner‐La Rocca, Hans‐Peter Bayes‐Genis, Antoni Lupón, Josep Yoshihisa, Akiomi Takeishi, Yasuchika Egstrup, Michael Gustafsson, Ida Gaggin, Hanna K. Eggers, Kai M. Huber, Kurt Gamble, Greg D. Ling, Lieng H. Leong, Kui Toh Gerard Yeo, Poh Shuah Daniel Ong, Hean Yee Jaufeerally, Fazlur Ng, Tze P. Troughton, Richard Doughty, Robert N. Devlin, Gerry Lund, Mayanna Giannoni, Alberto Passino, Claudio Emdin, Michele |
author_facet | Vergaro, Giuseppe Gentile, Francesco Aimo, Alberto Januzzi, James L. Richards, A. Mark Lam, Carolyn S.P. de Boer, Rudolf A. Meems, Laura M.G. Latini, Roberto Staszewsky, Lidia Anand, Inder S. Cohn, Jay N. Ueland, Thor Gullestad, Lars Aukrust, Pål Brunner‐La Rocca, Hans‐Peter Bayes‐Genis, Antoni Lupón, Josep Yoshihisa, Akiomi Takeishi, Yasuchika Egstrup, Michael Gustafsson, Ida Gaggin, Hanna K. Eggers, Kai M. Huber, Kurt Gamble, Greg D. Ling, Lieng H. Leong, Kui Toh Gerard Yeo, Poh Shuah Daniel Ong, Hean Yee Jaufeerally, Fazlur Ng, Tze P. Troughton, Richard Doughty, Robert N. Devlin, Gerry Lund, Mayanna Giannoni, Alberto Passino, Claudio Emdin, Michele |
author_sort | Vergaro, Giuseppe |
collection | PubMed |
description | AIMS: To define plasma concentrations, determinants, and optimal prognostic cut‐offs of soluble suppression of tumorigenesis‐2 (sST2), high‐sensitivity cardiac troponin T (hs‐cTnT), and N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) in women and men with chronic heart failure (HF). METHODS AND RESULTS: Individual data of patients from the Biomarkers In Heart Failure Outpatient Study (BIOS) Consortium with sST2, hs‐cTnT, and NT‐proBNP measured were analysed. The primary endpoint was a composite of 1 year cardiovascular death and HF hospitalization. The secondary endpoints were 5 year cardiovascular and all‐cause death. The cohort included 4540 patients (age 67 ± 12 years, left ventricular ejection fraction 33 ± 13%, 1111 women, 25%). Women showed lower sST2 (24 vs. 27 ng/mL, P < 0.001) and hs‐cTnT level (15 vs. 20 ng/L, P < 0.001), and similar concentrations of NT‐proBNP (1540 vs. 1505 ng/L, P = 0.408). Although the three biomarkers were confirmed as independent predictors of outcome in both sexes, the optimal prognostic cut‐off was lower in women for sST2 (28 vs. 31 ng/mL) and hs‐cTnT (22 vs. 25 ng/L), while NT‐proBNP cut‐off was higher in women (2339 ng/L vs. 2145 ng/L). The use of sex‐specific cut‐offs improved risk prediction compared with the use of previously standardized prognostic cut‐offs and allowed to reclassify the risk of many patients, to a greater extent in women than men, and for hs‐cTnT than sST2 or NT‐proBNP. Specifically, up to 18% men and up to 57% women were reclassified, by using the sex‐specific cut‐off of hs‐cTnT for the endpoint of 5 year cardiovascular death. CONCLUSIONS: In patients with chronic HF, concentrations of sST2 and hs‐cTnT, but not of NT‐proBNP, are lower in women. Lower sST2 and hs‐cTnT and higher NT‐proBNP cut‐offs for risk stratification could be used in women. |
format | Online Article Text |
id | pubmed-9288762 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92887622022-07-19 Circulating levels and prognostic cut‐offs of sST2, hs‐cTnT, and NT‐proBNP in women vs. men with chronic heart failure Vergaro, Giuseppe Gentile, Francesco Aimo, Alberto Januzzi, James L. Richards, A. Mark Lam, Carolyn S.P. de Boer, Rudolf A. Meems, Laura M.G. Latini, Roberto Staszewsky, Lidia Anand, Inder S. Cohn, Jay N. Ueland, Thor Gullestad, Lars Aukrust, Pål Brunner‐La Rocca, Hans‐Peter Bayes‐Genis, Antoni Lupón, Josep Yoshihisa, Akiomi Takeishi, Yasuchika Egstrup, Michael Gustafsson, Ida Gaggin, Hanna K. Eggers, Kai M. Huber, Kurt Gamble, Greg D. Ling, Lieng H. Leong, Kui Toh Gerard Yeo, Poh Shuah Daniel Ong, Hean Yee Jaufeerally, Fazlur Ng, Tze P. Troughton, Richard Doughty, Robert N. Devlin, Gerry Lund, Mayanna Giannoni, Alberto Passino, Claudio Emdin, Michele ESC Heart Fail Original Articles AIMS: To define plasma concentrations, determinants, and optimal prognostic cut‐offs of soluble suppression of tumorigenesis‐2 (sST2), high‐sensitivity cardiac troponin T (hs‐cTnT), and N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) in women and men with chronic heart failure (HF). METHODS AND RESULTS: Individual data of patients from the Biomarkers In Heart Failure Outpatient Study (BIOS) Consortium with sST2, hs‐cTnT, and NT‐proBNP measured were analysed. The primary endpoint was a composite of 1 year cardiovascular death and HF hospitalization. The secondary endpoints were 5 year cardiovascular and all‐cause death. The cohort included 4540 patients (age 67 ± 12 years, left ventricular ejection fraction 33 ± 13%, 1111 women, 25%). Women showed lower sST2 (24 vs. 27 ng/mL, P < 0.001) and hs‐cTnT level (15 vs. 20 ng/L, P < 0.001), and similar concentrations of NT‐proBNP (1540 vs. 1505 ng/L, P = 0.408). Although the three biomarkers were confirmed as independent predictors of outcome in both sexes, the optimal prognostic cut‐off was lower in women for sST2 (28 vs. 31 ng/mL) and hs‐cTnT (22 vs. 25 ng/L), while NT‐proBNP cut‐off was higher in women (2339 ng/L vs. 2145 ng/L). The use of sex‐specific cut‐offs improved risk prediction compared with the use of previously standardized prognostic cut‐offs and allowed to reclassify the risk of many patients, to a greater extent in women than men, and for hs‐cTnT than sST2 or NT‐proBNP. Specifically, up to 18% men and up to 57% women were reclassified, by using the sex‐specific cut‐off of hs‐cTnT for the endpoint of 5 year cardiovascular death. CONCLUSIONS: In patients with chronic HF, concentrations of sST2 and hs‐cTnT, but not of NT‐proBNP, are lower in women. Lower sST2 and hs‐cTnT and higher NT‐proBNP cut‐offs for risk stratification could be used in women. John Wiley and Sons Inc. 2022-05-05 /pmc/articles/PMC9288762/ /pubmed/35510529 http://dx.doi.org/10.1002/ehf2.13883 Text en © 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Vergaro, Giuseppe Gentile, Francesco Aimo, Alberto Januzzi, James L. Richards, A. Mark Lam, Carolyn S.P. de Boer, Rudolf A. Meems, Laura M.G. Latini, Roberto Staszewsky, Lidia Anand, Inder S. Cohn, Jay N. Ueland, Thor Gullestad, Lars Aukrust, Pål Brunner‐La Rocca, Hans‐Peter Bayes‐Genis, Antoni Lupón, Josep Yoshihisa, Akiomi Takeishi, Yasuchika Egstrup, Michael Gustafsson, Ida Gaggin, Hanna K. Eggers, Kai M. Huber, Kurt Gamble, Greg D. Ling, Lieng H. Leong, Kui Toh Gerard Yeo, Poh Shuah Daniel Ong, Hean Yee Jaufeerally, Fazlur Ng, Tze P. Troughton, Richard Doughty, Robert N. Devlin, Gerry Lund, Mayanna Giannoni, Alberto Passino, Claudio Emdin, Michele Circulating levels and prognostic cut‐offs of sST2, hs‐cTnT, and NT‐proBNP in women vs. men with chronic heart failure |
title | Circulating levels and prognostic cut‐offs of sST2, hs‐cTnT, and NT‐proBNP in women vs. men with chronic heart failure |
title_full | Circulating levels and prognostic cut‐offs of sST2, hs‐cTnT, and NT‐proBNP in women vs. men with chronic heart failure |
title_fullStr | Circulating levels and prognostic cut‐offs of sST2, hs‐cTnT, and NT‐proBNP in women vs. men with chronic heart failure |
title_full_unstemmed | Circulating levels and prognostic cut‐offs of sST2, hs‐cTnT, and NT‐proBNP in women vs. men with chronic heart failure |
title_short | Circulating levels and prognostic cut‐offs of sST2, hs‐cTnT, and NT‐proBNP in women vs. men with chronic heart failure |
title_sort | circulating levels and prognostic cut‐offs of sst2, hs‐ctnt, and nt‐probnp in women vs. men with chronic heart failure |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288762/ https://www.ncbi.nlm.nih.gov/pubmed/35510529 http://dx.doi.org/10.1002/ehf2.13883 |
work_keys_str_mv | AT vergarogiuseppe circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT gentilefrancesco circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT aimoalberto circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT januzzijamesl circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT richardsamark circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT lamcarolynsp circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT deboerrudolfa circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT meemslauramg circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT latiniroberto circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT staszewskylidia circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT anandinders circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT cohnjayn circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT uelandthor circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT gullestadlars circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT aukrustpal circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT brunnerlaroccahanspeter circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT bayesgenisantoni circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT luponjosep circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT yoshihisaakiomi circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT takeishiyasuchika circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT egstrupmichael circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT gustafssonida circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT gagginhannak circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT eggerskaim circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT huberkurt circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT gamblegregd circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT lingliengh circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT leongkuitohgerard circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT yeopohshuahdaniel circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT ongheanyee circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT jaufeerallyfazlur circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT ngtzep circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT troughtonrichard circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT doughtyrobertn circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT devlingerry circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT lundmayanna circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT giannonialberto circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT passinoclaudio circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure AT emdinmichele circulatinglevelsandprognosticcutoffsofsst2hsctntandntprobnpinwomenvsmenwithchronicheartfailure |